Nevro Corp. (NVRO)

Market Cap	1.17B
Revenue (ttm)	406.37M
Net Income (ttm)	3.00M
Shares Out	35.54M
EPS (ttm)	0.08
PE Ratio	412.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	369,487
Open	32.83
Previous Close	33.07
Day's Range	32.52 - 33.33
52-Week Range	28.75 - 78.90
Beta	0.82
Analysts	Sell
Price Target	45.39 (+37.55%)
Earnings Date	May 3, 2023

About NVRO

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 6, 2014
• Employees: 945
• Stock Exchange: NYSE
• Ticker Symbol: NVRO

Analyst Forecast

According to 20 analysts, the average rating for NVRO stock is "Sell." The 12-month stock price forecast is $45.39, which is an increase of 37.55% from the latest price.

Price Target

$45.39

(37.55% upside)

Analyst Consensus: Sell